Lise Roca

1.9k total citations
33 papers, 724 citations indexed

About

Lise Roca is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lise Roca has authored 33 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lise Roca's work include Cancer Treatment and Pharmacology (8 papers), Intraperitoneal and Appendiceal Malignancies (7 papers) and Breast Cancer Treatment Studies (7 papers). Lise Roca is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Intraperitoneal and Appendiceal Malignancies (7 papers) and Breast Cancer Treatment Studies (7 papers). Lise Roca collaborates with scholars based in France, United States and Belgium. Lise Roca's co-authors include Diane Goèré, Dominique Élias, F. Quénet, B. Saint‐Aubert, Frédéric Dumont, Sanket Mehta, Hélène de Forges, Valeria Loi, Pierre Méeus and Olivier Facy and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Surgery.

In The Last Decade

Lise Roca

32 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lise Roca France	12	382	266	252	158	100	33	724
Luis González Bayón Spain	15	458 1.2×	251 0.9×	184 0.7×	221 1.4×	127 1.3×	38	744
Chukwuemeka Ihemelandu United States	16	472 1.2×	333 1.3×	255 1.0×	210 1.3×	109 1.1×	28	778
L. Drouard-Troalen France	7	432 1.1×	249 0.9×	69 0.3×	196 1.2×	44 0.4×	10	538
Mehmet Füzün Türkiye	18	525 1.4×	87 0.3×	423 1.7×	31 0.2×	118 1.2×	39	853
Daniel S. Metzinger United States	14	344 0.9×	119 0.4×	93 0.4×	591 3.7×	194 1.9×	33	1.1k
Kouichi Miwa Japan	14	442 1.2×	66 0.2×	363 1.4×	138 0.9×	322 3.2×	31	853
Uwe Maeder Germany	9	227 0.6×	98 0.4×	183 0.7×	74 0.5×	67 0.7×	10	476
Hirotoshi Kobayashi Japan	21	1.2k 3.2×	83 0.3×	1.6k 6.3×	45 0.3×	711 7.1×	94	1.9k
Emmanuel Guardiola France	18	232 0.6×	38 0.1×	369 1.5×	72 0.5×	241 2.4×	36	726
Hee Sook Park South Korea	14	112 0.3×	38 0.1×	197 0.8×	24 0.2×	132 1.3×	49	531

Countries citing papers authored by Lise Roca

Since Specialization

Citations

This map shows the geographic impact of Lise Roca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lise Roca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lise Roca more than expected).

Fields of papers citing papers by Lise Roca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lise Roca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lise Roca. The network helps show where Lise Roca may publish in the future.

Co-authorship network of co-authors of Lise Roca

This figure shows the co-authorship network connecting the top 25 collaborators of Lise Roca. A scholar is included among the top collaborators of Lise Roca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lise Roca. Lise Roca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pouderoux, Stéphane, et al.. (2024). Exploring the Efficacy of Pembrolizumab in Combination with Carboplatin and Weekly Paclitaxel for Frail Patients with Advanced Non-Small-Cell Lung Cancer: A Key Investigative Study. Cancers. 16(5). 992–992. 1 indexed citations

Firmin, Nelly, Célia Touraine, Angélique Chapelle, et al.. (2021). A Phase II Multicenter Trial on High-Dose Vitamin D Supplementation for the Correction of Vitamin D Insufficiency in Patients with Breast Cancer Receiving Adjuvant Chemotherapy. Nutrients. 13(12). 4429–4429. 5 indexed citations

Viala, Marie, Nelly Firmin, Célia Touraine, et al.. (2021). Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer. BMC Cancer. 21(1). 815–815. 1 indexed citations

Hennequin, C., D. Azria, Pierre Blanchard, et al.. (2021). Specificities of clinical research in radiotherapy. Cancer/Radiothérapie. 26(1-2). 104–107.

Azambuja, Evandro de, Noam Pondé, Marion Procter, et al.. (2019). A pooled analysis of the cardiac events in the trastuzumab adjuvant trials. Breast Cancer Research and Treatment. 179(1). 161–171. 40 indexed citations

Quénet, François, Lise Roca, Sébastien Carrère, et al.. (2018). Two-stage hepatectomy for colorectal liver metastases: Pathologic response to preoperative chemotherapy is associated with second-stage completion and longer survival. Surgery. 165(4). 703–711. 4 indexed citations

Penault‐Llorca, Frédérique, Thomas Filleron, Bernard Asselain, et al.. (2018). The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial). BMC Cancer. 18(1). 526–526. 17 indexed citations

Guérif, S., I. Latorzeff, Lise Roca, et al.. (2017). The acute toxicity results of the GETUG-AFU 22 study: A multicenter randomized phase II trial comparing the efficacy of a short hormone therapy in combination with radiotherapy to radiotherapy alone as a salvage treatment for patients with detectable PSA after radical prostatectomy.. Journal of Clinical Oncology. 35(6_suppl). 16–16. 6 indexed citations

D’Hondt, Véronique, Frédéric Goffin, Lise Roca, et al.. (2016). Interval Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First-Line Treatment for Advanced Ovarian Carcinoma. International Journal of Gynecological Cancer. 26(5). 912–917. 11 indexed citations

10.

Jacot, William, Nelly Firmin, Lise Roca, et al.. (2016). Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study. Annals of Oncology. 27(7). 1235–1241. 24 indexed citations

11.

Guiu, Séverine, Lise Roca, Florence Dalenc, et al.. (2015). Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study. BMC Cancer. 15(1). 659–659. 33 indexed citations

12.

Duffour, Jacqueline, Audrey Combès, Evelyne Lopez‐Crapez, et al.. (2015). Reproductive Decision‐Making in MMR Mutation Carriers After Results Disclosure: Impact of Psychological Status in Childbearing Options. Journal of Genetic Counseling. 25(3). 432–442. 2 indexed citations

13.

Boissière‐Michot, Florence, Gwendal Lazennec, Marta Jarlier, et al.. (2014). Characterization of an adaptive immune response in microsatellite-instable colorectal cancer. OncoImmunology. 3(6). e29256–e29256. 74 indexed citations

14.

Roca, Lise, Véronique Dièras, Henri Roché, et al.. (2013). Correlation of HER2, FCGR2A, and FCGR3A gene polymorphisms with trastuzumab related cardiac toxicity and efficacy in a subgroup of patients from UNICANCER-PACS04 trial. Breast Cancer Research and Treatment. 139(3). 789–800. 48 indexed citations

15.

Kerbrat, Pierre, Bruno Coudert, Bernard Asselain, et al.. (2012). Abstract P1-13-04: Optimal duration of adjuvant chemotherapy for high risk node negative breast cancer patients: 6-year results of the prospective randomized phase III trial PACS 05.. Cancer Research. 72(24_Supplement). P1–13. 1 indexed citations

16.

Quénet, F., Diane Goèré, Sanket Mehta, et al.. (2011). Results of Two Bi-Institutional Prospective Studies Using Intraperitoneal Oxaliplatin With or Without Irinotecan During HIPEC After Cytoreductive Surgery for Colorectal Carcinomatosis. Annals of Surgery. 254(2). 294–301. 135 indexed citations

17.

Duffour, Jacqueline, Lise Roca, Françoise Bressolle, et al.. (2010). Clinical Impact of Intensified 5-Fluorouracil-Based Chemotherapy Using a Prospective Pharmacokinetically-Guided Dosing Approach: Comparative Study in Elderly and Non-Elderly Patients with Metastatic Colorectal Cancer. Journal of Chemotherapy. 22(3). 179–185. 11 indexed citations

18.

Aldabbagh, Kaïs, Stéphane Pouderoux, Lise Roca, et al.. (2010). Etoposide, mitomycin, and methotrexate combination in heavily treated breast cancer: a retrospective study. Breast Cancer. 19(1). 16–22. 4 indexed citations

19.

Roché, Henri, Djelila Allouache, Gilles Romieu, et al.. (2009). Five-Year Analysis of the FNCLCC-PACS04 Trial: FEC100 vs ED75 for the Adjuvant Treatment of Node Positive Breast Cancer.. Cancer Research. 69(24_Supplement). 602–602. 8 indexed citations

20.

Quénet, François, Lise Roca, Anaïs Gauthey, et al.. (2008). Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from digestive tract cancer—New management with oxaliplatin plus irinotecan: A feasibility study in 37 patients. Journal of Clinical Oncology. 26(15_suppl). 4084–4084. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact